After-hours movers: Chipotle Mexican Grill, Ford, IBM, Edwards Lifesciences, and more

Go back to After-hours movers: Chipotle Mexican Grill, Ford, IBM, Edwards Lifesciences, and more

Las Vegas Sands (LVS) PT Lowered to $56 at Macquarie

July 25, 2024 8:39 AM EDT

Macquarie analyst Chad Beynon lowered the price target on Las Vegas Sands (NYSE: LVS) to $56.00 (from $58.00) while maintaining a Outperform rating.

The analyst comments "2Q miss owing to renovation disruptions in Macau and Singapore. Ongoing construction remains an impact, but sets up for a much... More

TD Cowen Downgrades Edwards Lifesciences (EW) to Hold

July 25, 2024 7:17 AM EDT

TD Cowen analyst Joshua Jennings downgraded Edwards Lifesciences (NYSE: EW) from Buy to Hold with a price target of $70.00 (from $100.00).

The analyst comments "We are downgrading EW to Hold as we are now forecasting HSD revenue growth in 2024 and 2025 due to... More

ServiceNow (NOW) PT Raised to $880 at RBC Capital

July 25, 2024 6:39 AM EDT

RBC Capital analyst Matthew Hedberg raised the price target on ServiceNow (NYSE: NOW) to $880.00 (from $850.00) while maintaining a Outperform rating.

The analyst comments "Q2/24 showed nice upside and demonstrated impressive cRPO acceleration at scale while the increase in CY/24 subscription revenue guidance conveys the... More

IBM (IBM) PT Raised to $211 at RBC Capital

July 25, 2024 6:35 AM EDT

RBC Capital analyst Matthew Swanson raised the price target on IBM (NYSE: IBM) to $211.00 (from $200.00) while maintaining a Outperform rating.

The analyst comments "IBM delivered solid key metrics including upside to FCF which carried through to FY/25 guidance as well as... More

Edwards Lifesciences (EW) PT Lowered to $85 at RBC Capital

July 25, 2024 6:32 AM EDT

RBC Capital analyst Shagun Singh lowered the price target on Edwards Lifesciences (NYSE: EW) to $85.00 (from $101.00) while maintaining a Outperform rating.

The analyst comments "EW delivered Q2'24 results missing sales expectations and lowering 2024 operational revenue growth outlook to 8-10%... More

Ford (F) PT Lowered to $17 at Citi

July 25, 2024 5:47 AM EDT

Citi analyst Itay Michaeli lowered the price target on Ford (NYSE: F) to $17.00 (from $18.00) while maintaining a Buy rating.

The analyst comments "Q2 disappoints as two issues/risks noted in our preview (here) materialized (1) Cost containment (Q2 missed on another warranty hit); (2)... More

IBM (IBM) PT Raised to $190 at JPMorgan

July 25, 2024 5:10 AM EDT

JPMorgan analyst Brian Essex raised the price target on IBM (NYSE: IBM) to $190.00 (from $185.00) while maintaining a Neutral rating.

The analyst comments "Better than expected growth and margin expansion drive an EPS beat and a bump to FY24 FCF guidance. IBM delivered another quarter of better than expected Software growth, healthy AI deal traction, better than expected non-GAAP earnings, and better cash flow. Software performance was supported by Red Hat growth (although decelerated slightly this Q), accelerating Automation growth (aided by inorganic contribution), and better Transaction Processing... More

Edwards Lifesciences (EW) PT Lowered to $76 at Evercore ISI

July 25, 2024 4:59 AM EDT

Evercore ISI analyst Vijay Kumar lowered the price target on Edwards Lifesciences (NYSE: EW) to $76.00 (from $91.00) while maintaining a In Line rating.

The analyst comments "Thesis Update: This was tough call for EWthe rev miss, low quality EPS (~5c aid from discrete... More